Smoking Raises Risk of Lung Disease in RA - MedPage Today MedPage Today These changes are likely to reflect the earlier use of older immunosuppressive agents such as cyclophosphamide and the wider use of newer agents such as mycophenolate mofetil (CellCept) and rituximab (Rituxan), Kelly suggested. Earlier detection also ... |